GRIA3 and frontotemporal dementia: Recently, we identified anti- α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) antibodies, namely GluA3 subunit autoantibodies, in a few FTD cases screened at our centre13.